Related Experiment Videos
Detection of Chlamydia pneumoniae by polymerase chain reaction
L A Campbell1, M Perez Melgosa, D J Hamilton
1Department of Pathobiology, University of Washington, Seattle 98195.
Abstract:
While criteria for serodiagnosis of Chlamydia pneumoniae infection are well established, isolation of the organism is often difficult. To increase detection of this organism, C. pneumoniae-specific sequences were identified to permit amplification of C. pneumoniae by polymerase chain reaction (PCR). A cloned C. pneumoniae 474-bp PstI fragment was shown by dot blot and Southern hybridization to differentiate C. pneumoniae from the other Chlamydia spp., react with all C. pneumoniae isolates tested, and not recognize DNA from normal throat flora or common respiratory tract agents. This cloned fragment was sequenced and primers for use in PCR were chosen on the bases of GenBank analysis, G + C ratio, and absence of secondary structure. All C. pneumoniae isolates tested were amplified by the HL-1-HR-1 primer pair or the HM-1-HR-1 primer pair, producing the expected 437- and 229-bp amplification products, respectively. None of the Chlamydia trachomatis serovars (B/TW-5/OT, C/TW-3/OT, D/UW-3/Cx, E/UW-5/Cx, F/UW-6/Cx, H/UW-4/Cx, I/UW-12/Ur, and L2/434/Bu), Chlamydia psittaci strains (Mn, 6BC, GPIC, FP, and OA), HeLa cells, or other organisms tested were amplified. Reaction conditions including MgCl2, oligonucleotides, and primer concentrations and temperature were optimized before application to clinical samples. Clinical specimens from patients from whom C. pneumoniae was isolated were also positive by PCR, while samples from patients with known C. trachomatis or C. psittaci infection were not amplified by PCR.
Insights
Developing a new polymerase chain reaction (PCR) assay for Chlamydia pneumoniae detection improves upon traditional methods. This highly specific PCR test accurately identifies C. pneumoniae in clinical samples, overcoming challenges with organism isolation.
Area of Science:
- Molecular Biology
- Microbiology
- Infectious Diseases
Background:
- Serodiagnostic criteria for Chlamydia pneumoniae infection are established.
- Isolation of Chlamydia pneumoniae is frequently challenging in clinical settings.
- Need for improved diagnostic methods for Chlamydia pneumoniae detection.
Purpose of the Study:
- To develop a highly specific polymerase chain reaction (PCR) assay for Chlamydia pneumoniae detection.
- To identify Chlamydia pneumoniae-specific DNA sequences for amplification.
- To overcome difficulties associated with direct organism isolation.
Main Methods:
- Identification and cloning of a Chlamydia pneumoniae-specific 474-bp PstI fragment.
- Selection and optimization of primer pairs (HL-1-HR-1 and HM-1-HR-1) for PCR amplification.
- Validation using dot blot, Southern hybridization, and PCR on various Chlamydia species, cell lines, and clinical specimens.
Main Results:
- The cloned fragment specifically recognized Chlamydia pneumoniae DNA, differentiating it from other Chlamydia species and common respiratory organisms.
- Optimized PCR assays successfully amplified Chlamydia pneumoniae from all tested isolates, producing specific product sizes (437-bp and 229-bp).
- The PCR assay demonstrated high specificity, with no amplification observed for Chlamydia trachomatis, Chlamydia psittaci, or other tested microorganisms.
- Clinical specimens from patients with confirmed Chlamydia pneumoniae infections tested positive via PCR.
Conclusions:
- A novel, highly specific PCR assay targeting Chlamydia pneumoniae DNA has been developed.
- This PCR method offers a sensitive and reliable alternative for diagnosing Chlamydia pneumoniae infections, especially when organism isolation is difficult.
- The assay shows potential for accurate clinical application in identifying Chlamydia pneumoniae.